XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements Of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Total revenues
Operating expenses:        
Research and development 68,605 58,499 130,759 106,428
General and administrative 17,845 11,774 34,027 21,432
Total operating expenses 86,450 70,273 164,786 127,860
Loss from operations (86,450) (70,273) (164,786) (127,860)
Interest income 3,551 323 7,327 392
Interest expense (2,901) (780) (5,237) (780)
Net loss $ (85,800) $ (70,730) $ (162,696) $ (128,248)
Net loss per common share:        
Basic net loss per common share $ (4.69) $ (4.14) $ (8.91) $ (7.5)
Diluted net loss per common share $ (4.69) $ (4.14) $ (8.91) $ (7.5)
Basic weighted average number of common shares outstanding 18,310,952 17,103,395 18,249,778 17,103,395
Diluted weighted average number of common shares outstanding 18,310,952 17,103,395 18,249,778 17,103,395